Bausch Health 预计2026年收入为55.25亿至56.25亿美元，同时概述第四季度Xifaxan面临的逆风 (NYSE:BHC)
· seekingalpha.com
Bausch Health 2026年第三季度财报：上调指引，EBITDA突破10亿美元，削减债务，但指出第四季度Xifaxan面临逆风。
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...